THE RESPONSE OF LORLATINIB TREATMENT COMBINED WITH CHEMOTHERAPY AND CRANIOSPINAL RADIOTHERAPY ON CENTRAL NERVOUS SYSTEM RELAPSE OF HIGH-RISK NEUROBLASTOMA WITH ALKF1174 L MUTATION

被引：0
|
作者：
Cecen, Emre [1 ]
Ince, Dilek [1 ]
Aktas, Safiye [2 ]
Kizmazoglu, Deniz [1 ]
Guleryuz, Handan [3 ]
Aktas, Tekincan [2 ]
Kizmazoglu, Ceren [4 ]
Olgun, Nur [1 ]
机构：
[1] Dokuz Eylul Univ, Pediat Oncol, Inst Oncol, Izmir, Turkey
[2] Dokuz Eylul Univ, Basic Oncol Dept, Inst Oncol, Izmir, Turkey
[3] Dokuz Eylul Univ, Radiol, Izmir, Turkey
[4] Dokuz Eylul Univ, Neurosurg, Izmir, Turkey
来源：
PEDIATRIC BLOOD & CANCER | 2022年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO065
引用
收藏
页码：S594 / S594
页数：1
相关论文
共 12 条
  • [1] Intrinsic Susceptibility MRI Identifies Tumors with ALKF1174L Mutation in Genetically-Engineered Murine Models of High-Risk Neuroblastoma
    Jamin, Yann
    Glass, Laura
    Hallsworth, Albert
    George, Rani
    Koh, Dow-Mu
    Pearson, Andrew D. J.
    Chesler, Louis
    Robinson, Simon P.
    PLOS ONE, 2014, 9 (03):
  • [2] WHOLE NEURAXIS IRRADIATION TO ADDRESS CENTRAL NERVOUS SYSTEM RELAPSE IN HIGH-RISK NEUROBLASTOMA
    Croog, Victoria J.
    Kramer, Kim
    Cheung, Nai-Kong V.
    Kushner, Brian H.
    Modak, Shakeel
    Souweidane, Mark M.
    Wolden, Suzanne L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : 849 - 854
  • [3] Intrinsic susceptibility magnetic resonance imaging identifies tumors with ALKF1174L mutation in transgenic murine models of high-risk neuroblastoma.
    Jamin, Yann
    Glass, Laura
    Hallsworth, Albert
    George, Rani E.
    Koh, Dow-Mu
    Pearson, Andrew D. J.
    Chesler, Louis
    Robinson, Simon P.
    CANCER RESEARCH, 2013, 73 (08)
  • [4] Whole neuraxis irradiation to address central nervous system (CNS) relapse in high-risk neuroblastoma (NB)
    Croog, V. J.
    Kramer, K.
    Kushner, B.
    Chung, K. Y.
    Modak, S.
    Souweidane, M.
    Wolden, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Recent Treatment Analysis of 42 Children with Central Nervous System and Intracranial Metastases in High-Risk Neuroblastoma
    Jin, M.
    Zhang, D.
    Zhao, W.
    Wang, X.
    Zhao, Q.
    Li, X.
    Huang, C.
    Hao, T.
    Yue, Z.
    Ma, X.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S196 - S197
  • [6] Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience
    Berlanga, P.
    Pasqualini, C.
    Poetschger, U.
    Sanguesa, C.
    Castellani, M. R.
    Canete, A.
    Luksch, R.
    Elliot, M.
    Schreier, G.
    Kropf, M.
    Morgenstern, D.
    Papadakis, V.
    Ash, S.
    Ruud, E.
    Brock, P.
    Wieczorek, A.
    Kogner, P.
    Trahair, T.
    Ambros, P.
    Boterberg, T.
    Castel, V.
    Valteau-Couanet, D.
    Ladenstein, R.
    EUROPEAN JOURNAL OF CANCER, 2021, 144 : 1 - 8
  • [7] Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse
    Flaadt, Tim
    Ebinger, Martin
    Schreiber, Malin
    Ladenstein, Ruth L.
    Simon, Thorsten
    Lode, Holger N.
    Hero, Barbara
    Schuhmann, Martin U.
    Schaefer, Jurgen
    Paulsen, Frank
    Timmermann, Beate
    Eggert, Angelika
    Lang, Peter
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
  • [8] Treatment of isolated central nervous system relapse in high-risk lymphoid malignancy with allogeneic bone marrow transplantation and extended intrathecal therapy
    Nagatoshi, Y
    Kawano, Y
    Nagayama, J
    Okamura, J
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (06) : 766 - 768
  • [9] MRI abnormalities in children following sequential chemotherapy, hyperfractionated accelerated radiotherapy and high-dose thiotepa for high-risk primitive neuroectodermal tumours of the central nervous system
    Thust, Stefanie C.
    Blanco, Esther
    Michalski, Antony J.
    Chong, W. K.
    Gaze, Mark N.
    Phipps, Kim
    Mankad, Kshitij
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2014, 58 (06) : 683 - 690
  • [10] Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients
    Ferreri, AJM
    Reni, M
    Dell'Oro, S
    Ciceri, F
    Bernardi, M
    Camba, L
    Ponzoni, M
    Terreni, MR
    Tomirotti, M
    Spina, M
    Villa, E
    ONCOLOGY, 2001, 60 (02) : 134 - 140
12